Renal Cancers Recruiting Phase 2 Trials for Ipilimumab (DB06186)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03065179Trial of SBRT in Combination With Nivolumab/Ipilimumab in RCC / Kidney Cancer PatientsTreatment
NCT03203473Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)Treatment